Funding
Renapharma
Open access funding provided by Karolinska Institute. The original study was initiated by investigators and supported by Uppsala University. Renapharma AB, Sweden was the sponsor of the study. Renapharma AB provided study medication, monitoring, and financial support for laboratory analyses.